Elevated resting and agonist-induced whole blood chemiluminescence in patients with active infective endocarditis

Stanislaw Ostrowski1, Marek Kasielski, Jacek Kordiak

  • 1Departament of Cardiosurgery, Medical University of Lodz, Poland.

Insights

Patients with infective endocarditis (IE) show higher oxidant production by phagocytes, measured by luminol-enhanced whole blood chemiluminescence (LBCL). This elevated oxidative activity may increase the risk of oxidative stress in IE patients.

Area of Science:

  • Immunology
  • Cardiovascular Medicine
  • Biochemistry

Background:

  • Infective endocarditis (IE) and cardiac surgery involve inflammatory responses impacting phagocyte oxidant production.
  • Phagocyte-derived oxidants play a role in inflammation and tissue damage.

Purpose of the Study:

  • To evaluate luminol-enhanced whole blood chemiluminescence (LBCL) as a measure of oxidative production by circulating phagocytes.
  • To compare oxidative production in IE patients, valvular heart disease patients, and healthy controls.

Main Methods:

  • LBCL was measured in 26 IE patients, 27 valvular heart disease patients, and 25 healthy controls.
  • Blood samples were collected pre-surgery and at multiple time points post-valve replacement.
  • Resting (rCL) and stimulated (fMLP-induced, tCL) chemiluminescence were assessed.

Main Results:

  • Preoperative LBCL (rCL and tCL) was significantly higher in IE patients compared to healthy controls and valvular heart disease patients.
  • IE patients exhibited approximately 2.5-fold higher median preoperative rCL and tCL than valvular heart disease patients.
  • LBCL increased significantly in both operated groups three days post-surgery, decreasing with recovery.

Conclusions:

  • Infective endocarditis is associated with elevated LBCL, indicating increased oxidant release from circulating phagocytes.
  • Elevated phagocyte oxidant production in IE may contribute to the development of oxidative stress.
  • LBCL serves as a valuable indicator of phagocyte oxidative activity in cardiovascular conditions.

Related Concept Videos

Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...